概括
沙莫醇在心力衰竭患者中没有改善临床症状或运动能力. 然而,与安慰剂相比,它减少了喘息,但增加了死亡风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心力衰竭是一种复杂的综合征,需要有效的治疗方法.
- 目前的治疗方法,如利尿剂和ACE抑制剂,是纽约心脏协会 (NYHA) 标准的III和IV级HF.
- 为了改善HF的治疗结果,不断研究新型治疗药物.
研究的目的:
- 评估Xamoterol在患有严重心力衰竭的患者中的疗效和安全性.
- 评估沙莫特醇对临床征兆,症状,运动能力和死亡率的影响.
主要方法:
- 一个双盲的,跨群体的比较研究.
- 516名NYHA三级/四级心力衰竭患者被随机分类.
- 患者在13周内每天两次接受Xamoterol200mg或安慰剂.
主要成果:
- 在Xamoterol和安慰剂组之间,临床症状的消失没有显著差异.
- 克萨莫特罗尔减少了呼吸困难,但没有改善炼时间或完成的工作.
- 沙莫醇降低了心率和血压,没有增加心室过早跳动或心律失常活性.
- 治疗意图分析显示,在Xamoterol组 (9.1%) 与安慰剂 (3.7%) 的100天内死亡率显著更高 (p=0.02).
结论:
- 沙莫在严重心力衰竭患者中没有显示出临床益处.
- 虽然沙莫特醇可以缓解呼吸困难,但它与死亡风险增加有关.
- 需要进一步调查沙莫在心力衰竭中的安全性.
相关概念视频
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...